Ex parte SKELBAEK et al. - Page 3





                        Appeal No. 1998-2536                                                                                                                         Page 3                                  
                        Application No. 08/710,690                                                                                                                                                           



                                          least 10% by weight of highly unsaturated fatty acids which is                                                                                                     
                                          dispersed in a matrix material comprising caseinate, and a                                                                                                         
                                          pharmaceutically acceptable carrier.                                                                                                                               

                                                                                    CITED PRIOR ART                                                                                                          

                                          As evidence of unpatentability, the Examiner relies on the following                                                                                               

                              reference:                                                                                                                                                                     

                              Janda et al.  (Janda)                                                   WO92/05708                                      Apr. 16, 1992                                          
                                          (Published PCT application)                                                                                                                                        

                                          The Examiner rejected claims 1 to 6, 16 to 18, 25 and 26 under 35 U.S.C.     §                                                                                     

                                                                                2                                                                                                                            
                              103(a) as obvious over Janda.  (Answer, p. 3.)                                                                                                                                 

                                          We reverse the aforementioned rejection.  We need to address only the                                                                                              

                              independent claims, i.e., claims 1, 16 and 17.                                                                                                                                 






                                          The Appellants’ claims 1, 16 and 17 all require the oil or fat, that is dispersed                                                                                  

                              in the matrix material, to contain at least 10% by weight of highly unsaturated fatty                                                                                          



                                          2The Appellants, in the Brief, have inadvertently referred to the Janda reference as US                                                                            
                              5,013,569.  (Brief, p. 2.)  The Examiner in both the Final Rejection and the Answer has rejected the                                                                           
                              claims over the WO92/05708 Janda document.  The Appellants have not indicated, by filing a Reply                                                                               
                              Brief, the Examiner was in error.  Therefore, we will address the rejection as presented by the                                                                                
                              Examiner.                                                                                                                                                                      










Page:  Previous  1  2  3  4  5  6  7  Next 

Last modified: November 3, 2007